NEW DELHI: The Serum Institute of India and Bharat Biotech are expected to conduct advanced stage clinical trials of intranasal Covid-19 vaccines in the coming months once they receive regulatory approval, Union Health Minister Harsh said on Sunday Vardhan.
Vardhan said the late-stage trial typically involves thousands of participants, sometimes 30,000 to 40,000.
Of the vaccines currently in phase 3 trials, all are given by injection, according to the World Health Organization (WHO).
On Saturday, India’s Dr Reddy’s Laboratories Ltd and Russia’s Direct Investment Fund (RDIF) said they had received renewed approval to carry out late-stage clinical trials of the Russian COVID-19 vaccine in India.
Coronavirus infections in India rose by 61,871 in the past 24 hours, data released Sunday showed, although the Health Ministry said it is seeing a steady decline in active cases.
The Indian Council for Medical Research (ICMR) said it will review its protocol for the treatment of Covid-19 after the WHO found that some of the commonly used drugs, including remdesivir, had little to no impact on chances of survival. of a patient.
Vardhan said the late-stage trial typically involves thousands of participants, sometimes 30,000 to 40,000.
Of the vaccines currently in phase 3 trials, all are given by injection, according to the World Health Organization (WHO).
On Saturday, India’s Dr Reddy’s Laboratories Ltd and Russia’s Direct Investment Fund (RDIF) said they had received renewed approval to carry out late-stage clinical trials of the Russian COVID-19 vaccine in India.
Coronavirus infections in India rose by 61,871 in the past 24 hours, data released Sunday showed, although the Health Ministry said it is seeing a steady decline in active cases.
The Indian Council for Medical Research (ICMR) said it will review its protocol for the treatment of Covid-19 after the WHO found that some of the commonly used drugs, including remdesivir, had little to no impact on chances of survival. of a patient.
.
